Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nicotine receptors found for the first time in the mouth open the door to new treatments

20.01.2009
* Gabinete de Planeamento, Estratégia, Avaliação e Relações Internacionais / Ministério da Ciência, Tecnologia e Ensino Superior

A research team by scientists in Portugal and the US has found for the first time nicotine receptors in the taste buds. In fact, although most of the toxicity of smoking is linked to other components, it is nicotine that leads to smoking addiction and until now it was believed that this substance had to migrate into the brain – where its specific receptors existed - to provoke its effects.

This new discovery published in the Proceedings of the National Academy of Sciences (PNAS) reveals a second recognition pathway most probably contributing for addiction and suggesting a possible new target for anti-smoking drugs. The added bonus is that on this route the drugs can be applied topically (on the tongue), drastically reducing their side effects. This novel pathway is also shown to activate a brain area that when damaged can lead to instant loss of smoking addiction suggesting that mouth nicotine receptors can play a key role in the whole dependence process.

Tobacco addiction produces devastating health problems including high number of premature deaths in long-term smokers, half of these occurring as early as middle age. Specific problems include cardiovascular diseases and cancer, but also increased risk of infection such as tuberculosis, insulin resistance and diabetes, healing difficulties as well as reproductive problems and can even lead to infertility. Despite this, just in the United States, 45 million adults smoke and even if numbers are slowly diminishing in developed countries, rates continue to increase in developing countries where as much as 40% of the population can smoke. This while we know that, at least in developed countries, a large percentage of these smokers want to give up but is simply incapable of doing it.

This irresistible power of tobacco, or more exactly, of nicotine, resides in its effect on the brain. Smoke inhalation results in nicotine being transported into the lung from where it enters the blood circulation and is carried into the brain. There it binds nicotinic cholinergic receptors (nAChRs) and ultimately leads to the release of “feel good” neurotransmitters, such as dopamine. The problem is that long-term exposure to nicotine leads to an increased number of nicotine receptors in the brain and eventually tolerance to dopamine. This means that when we stop smoking other stimulus are not sufficient to produce enough dopamine to induce sensations of pleasure, and a general state of “unhappiness” - so well known to those trying to stop the habit – occurs. Withdrawal symptoms include restlessness, anxiety, concentration problems and, of course, a constant craving for tobacco.

Other factors such as culture or even habits of association such as “a coffee and a cigarette” contribute to the whole pattern of addiction. Drugs to combat smoke addiction interfere with the nicotine receptors in the brain, while slowly desensitising the individual to dopamine but, not only they carry a multitude of side effects, such as severe depression, but also have reduced success rates with only about 20% of people remaining smoke-free on the long-term. Recently, widespread prohibition of smoking in public spaces was hoped to affect smoking numbers but results, so far, are not very promising highlighting the urgency for new strategies to combat the problem.

It is in this context that Albino J. Oliveira-Maia, Jennifer R. Stapleton-Kotloski, Miguel A. L. Nicolelis, Sidney A. Simon and colleagues at the Medicine Faculty and the Institute of Cellular and Molecular Biology in the University of Porto, Portugal; Virginia Commonwealth University, Virginia, USA; Duke University Medical Center, North Carolina, USA; and the Edmond and Lily Safra International Institute for Neuroscience of Natal, Rio Grande do Norte, Brazil, decided to look into a recently described mouse lacking a protein - called TRPM5 - linked to the recognition of bitter tastes (nicotine is known to be bitter) since previous research have suggested that taste is important for tobacco addiction. In fact individuals with an extreme capacity to taste bitterness are more resistant to smoke addiction, while lesions to the insula – a brain area where the gustatory cortex is localised – can affect smoking addiction.

To the researchers’ surprise, when comparing normal animals against animals lacking TRPM5 in the presence of nicotine and quinine (that also has a bitter taste) solutions, it was discovered that, although incapable of tasting bitter tastes, Trpm5 negative animals could still distinguish nicotine from water and, more surprisingly, also from quinine. These results suggested a second pathway of recognition- which is TRPM5 and taste independent - for nicotine in the mouth.

And in fact, further studies in rats revealed the existence of nicotine receptors in the Taste Receptor Cells and taste nerves of the mouth, which, when triggered by nicotine, activated the gustatory cortex with a very different neural pattern from the one obtained by the recognition of pure bitter taste, like in quinine case. However, when nicotinic cholinergic receptors (nAChRs) inhibitors – used to stop smoking - were put on the tongue, both the behavioural and neural effects of nicotine became similar to those obtained with quinine.

What Oliveira-Maia, Simon and colleagues’ results reveal is that nicotine stimulates two systems in the mouth, one related to TRPM5, which is also used to recognise other bitter substances such as quinine, and a second one apparently specific for nicotine and Trpm5 independent. This last recognition system leads to an unique neural activation pattern of the gustatory cortex probably linked to nicotine addiction. The clue to this resides in the fact that damage in the brain insula area – where the gustatory cortex is – can eliminate any addiction to tobacco even in chronic smokers using several packets a day just before the injury. If the mouth nicotine receptors are confirmed to be linked with these insula effects, blocking them can turn out to be "the" weapon against smoking.

Either way, Oliveira-Maia and colleagues’ discovery raises the possibility of, not only using anti-smoking drugs topically avoiding in this way many of the side effects seen when the drugs are used sistemically, but also, by creating a second front of attack, contributing to more efficient anti-smoking therapies crucial in a world where smoking still kills more than 5 million people a year worldwide.

Piece by Catarina Amorim (catarina.amorim at linacre.ox.ac.uk)

Catarina Amorim | alfa
Further information:
http://www.pnas.org/

More articles from Health and Medicine:

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

nachricht How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>